John Haudrich
Analyst · Baird. Your line is open. Please go ahead
Thank you, Andres, and good morning, everyone. I'm on Slide 7. As Andres mentioned, our second quarter results were $0.01 per share, which was consistent with our most recent business update. Let me walk through our earnings reconciliation on the right. Segment operating profit was $95 million, which compared to $236 million in the prior year. As noted, FX was a $6 million headwind. Higher selling prices offset cost inflation, which was elevated due to FX induced inflation, especially in Latin America. Sales volume and mix was an $84 million headwind, which was fully attributed to the pandemic. This reflected a 15% decline in shipment levels plus the impact at our JVs. Operating costs were a $52 million headwind, which is the net effect of lower production and improved operating and cost performance. Production was down 20%, which impacted results by $109 million. The decline in production levels exceeded the decline in sales volume. This reflected our disciplined efforts to align supply with lower demand and control inventory levels, as well as the forced curtailment to comply with government decrease to address the virus. In particular, forced curtailment was drastic in both Mexico and the Andeans. Lower production was partially offset by $57 million in benefits from our turnaround initiatives and other cost control efforts. We expect the clear majority of these savings will be sustained and benefit future earnings. Non-operating items including lower interest expense, following the recent refinancing activities. Our tax rate was elevated reflecting a shift in regional EBIT mix and other factors, given lower earnings. We will likely contend with an elevated tax rate for the balance of the year, which will not impact cash in 2020. All of these results pertain to adjusted earnings. The appendix includes more details on items, management does not consider representative of ongoing operations. These include charges for employee severance related to our recent reduction in force initiative, refinancing costs as we retired near-term debt, as well as restructuring, primarily related to one site in Latin America. We continue to expect 2020 cash restructuring will approximate prior year levels. Bottom line, adjusted EPS was $0.01 compared to $0.69 in the prior year, as earnings were significantly impacted by lower volumes due to the pandemic, partially offset by favorable operating and cost performance. Moving to Slide 8, let me share a little color on regional performance during the quarter. In the Americas, profit was $52 million, down $88 million on a currency neutral basis. Higher selling prices, mostly offset cost inflation, which was elevated due to FX induced inflation in Latin America. Sales volumes were down 18% during the quarter, but improved significantly later in the period and shipments were down about 8% in June. During June volumes were about flat in North America and down high single-digits across most of Latin America. The exception was the Andean countries, which were still down double-digits. In July sales volume was up low single-digits across the Americas, including mid-single-digit growth in North America. Second quarter production was down as we balance supply with demand and comply with government decrease. Improved operating performance and cost controls partially offset the impact of the pandemic. Europe's operating profit was $42 million, down $45 million on a currency neutral basis. Higher selling prices more than offset cost inflation, which included the benefit of the region's revenue optimization efforts. Sales volumes were down 14% during the second quarter, but improved as markets began to reopen. June sales volumes were up 3% in the region and shipments were down slightly in July. Like the Americas, second quarter production was lower than last year to control inventory and improved operating performance and cost controls help to mitigate the impact of lower volumes. Asia Pacific's operating profit was $1 million, which was comparable to the prior year. As noted, we completed the sale of ANZ last week, which is the clear majority Asia Pacific segment. Pro forma information is provided in the appendix. Let's shift to cash flows and the balance sheet. I'm now on Slide 10. We are operating under a set a specific capital allocation principles amid the pandemic. Let me review these principles and the progress we have made through mid-year. First, we are squarely focused on maximizing free cash flow. To support this, we are aligning supply with demand and limiting CapEx to normal maintenance investment in MAGMA. We have been making very good progress. Our second quarter free cash flow was $112 million, despite this period often being a seasonal use of cash for business. In fact, cash flow was about $160 million higher than the prior year, normalized for changes in AR factoring activity. Likewise, the Paddock Chapter 11 process has suspended any asbestos-related payments. All of this reflects a highly disciplined focus on cash and capital management, as our year-to-date cash flows compare favorably to the prior year. Second, we are preserving our strong liquidity. Despite the pandemic, our committed liquidity actually improved during the second quarter and exceeded $1.8 billion at mid-year. This is well above the liquidity floor we have identified for 2020. Third, we are reducing debt. As illustrated on the chart, net debt was $5.4 billion as of mid-year, which compared favorably both to the prior year period and first quarter levels. Our leverage ratio at mid-year was 4.1 for our bank credit agreement, which was just slightly higher than the first quarter despite the pandemic and well below our covenant limit of 5.0. With the completion of ANZ divestiture last week, net proceeds are being used to improve the balance sheet. We have already repaid over $350 million in debt and the remaining debt reduction will occur in the near future. As our tactical divestiture program continues, we are in advanced stages on the sale of a few close plant properties. While minor, we expect the transaction should be completed by year-end. All these actions will further improve our leverage position and we are highly confident O-I will remain in compliance with its bank covenant in 2020. Overall, we are making solid progress on our capital allocation priorities in 2020, despite the challenges of the pandemic. Let me wrap up with a few comments on our business outlook. I'm now on Slide 11. While we believe the worst of the pandemic is behind us, significant uncertainties remain, given O-I's earning sensitivities to changes in volume, we are not providing specific earnings and cash flow guidance. We will consider reinstating guidance in the future, when there is more market and public health stability. However, we are providing our best estimates on demand trends, which could change due to the fluid nature of COVID-19. Reflecting recent favorable trends, we now expect our full-year 2020 sales volume will be down between 4% and 7% compared to the prior year. This reflects a more favorable outlook compared to our previous guidance of down 5% to 10% in 2020. Given the recent trends, we expect third quarter sales volumes will be flat to modestly lower than prior year. Yet, we do expect third quarter production levels will be down 7% to 10% compared to last year, as we continue to trim our IDS levels. Most of this rebalancing is complete in our IDS at the end of July was below the prior year. After this quarter, production should be aligned with sales volume trends. Please note that our sales volume outlook has been normalized for the divestiture of ANZ, effective July 31. We do anticipate providing continued regular business updates during the pandemic that will include our evolving business outlook. With that, I'll turn it back to Andres.